NEWS: Weight Loss Drug Poses Safety Risks

Qnexa is the new drug that is manufactured by Vivus Inc. According to the experts at the Food and Drug Administration, this new drug poses risks of psychiatric side effects to its users. The Food and Drug Administration states that Qnexa may need to be examined closely in order to determine its side effects on the nervous system.

The Food and Drug Administration recognizes the drug’s potential and effectiveness for cutting weight. However, according to the FDA’s initial examination of the drug, they have found out that there are some concerns about some of the drug’s side effects. There were reports of depression, memory lapses, concentration difficulties, and heart-related problems.

According to the FDA, weight loss drugs such as Qnexa may gain a great amount of exposure because of the current rate of obesity in the United States. Because of this, the associated side effects of this drug can greatly pose safety risks to the population.

Qnexa is a newly introduced weight loss drug that is undergoing screening by the FDA. With the growing rate of obesity, the FDA has to ensure that the drugs being sold in the weight loss market are not harmful to one’s health.

Related Posts:

NEWS: Weight Loss Drug Linked to Liver Problems

NEWS: Diet Supplement Recalled for Safety of Consumers

Identifying Bogus Weight Loss Supplements

Europe Banned an Anti-obesity Drug

NEWS: Green Tea Can Promote Weight Loss According to Latest Studies